GAMCO INVESTORS, INC. ET AL - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 193 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$7,284,647
+4.4%
219,351
-0.9%
0.08%
-4.9%
Q3 2022$6,978,000
-9.5%
221,306
-12.7%
0.08%
-3.5%
Q2 2022$7,708,000
+17.2%
253,4000.0%0.08%
+44.1%
Q1 2022$6,578,000
+26.0%
253,400
-1.0%
0.06%
+31.1%
Q4 2021$5,222,000
+10.3%
256,000
+4.1%
0.04%
+7.1%
Q3 2021$4,733,000
+3.6%
246,000
+19.4%
0.04%
+7.7%
Q2 2021$4,569,000
-16.3%
206,000
-1.0%
0.04%
-18.8%
Q1 2021$5,460,000
+38.4%
208,000
-1.4%
0.05%
+29.7%
Q4 2020$3,944,000
+10.1%
211,0000.0%0.04%
-7.5%
Q3 2020$3,583,000
-29.4%
211,000
-3.2%
0.04%
-31.0%
Q2 2020$5,077,000
+158.2%
218,000
-6.8%
0.06%
+152.2%
Q1 2020$1,966,000
-17.5%
234,000
-4.1%
0.02%
+21.1%
Q4 2019$2,384,000
+14.2%
244,000
+10.9%
0.02%
+11.8%
Q3 2019$2,088,000
+7.2%
220,000
+34.1%
0.02%
+13.3%
Q2 2019$1,948,000
-32.5%
164,0000.0%0.02%
-31.8%
Q1 2019$2,888,000
+1.4%
164,0000.0%0.02%
-8.3%
Q4 2018$2,847,000
+16.5%
164,0000.0%0.02%
+41.2%
Q3 2018$2,444,000
-10.6%
164,000
-4.7%
0.02%
-10.5%
Q2 2018$2,735,000
+10.1%
172,000
-1.7%
0.02%
+11.8%
Q1 2018$2,485,000
+1.4%
175,0000.0%0.02%
+13.3%
Q4 2017$2,450,000
-2.1%
175,0000.0%0.02%0.0%
Q3 2017$2,503,000
-9.2%
175,0000.0%0.02%
-16.7%
Q2 2017$2,756,000
+14.1%
175,0000.0%0.02%
+20.0%
Q1 2017$2,415,000
-2.5%
175,000
+25.0%
0.02%
-6.2%
Q4 2016$2,478,000
-8.3%
140,0000.0%0.02%
-11.1%
Q3 2016$2,701,000
-1.1%
140,0000.0%0.02%0.0%
Q2 2016$2,730,000
-5.4%
140,0000.0%0.02%
-5.3%
Q1 2016$2,885,000
+0.4%
140,0000.0%0.02%0.0%
Q4 2015$2,873,000
+20.0%
140,0000.0%0.02%
+18.8%
Q3 2015$2,394,000
-7.6%
140,000
+0.7%
0.02%
+14.3%
Q2 2015$2,591,000
-2.3%
139,0000.0%0.01%0.0%
Q1 2015$2,652,000
+15.9%
139,0000.0%0.01%
+16.7%
Q4 2014$2,288,000
-7.6%
139,000
-0.7%
0.01%
-7.7%
Q3 2014$2,477,000
-7.7%
140,000
+7.7%
0.01%
-7.1%
Q2 2014$2,683,000
+33.8%
130,000
+41.3%
0.01%
+27.3%
Q1 2014$2,005,000
-16.0%
92,000
+2.2%
0.01%
-15.4%
Q4 2013$2,388,000
+12.3%
90,0000.0%0.01%
+8.3%
Q3 2013$2,127,000
+9.9%
90,0000.0%0.01%0.0%
Q2 2013$1,935,00090,0000.01%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q2 2020
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders